Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Olanzapine Proves Effective in Breakthrough CINV
May 16th 2012, 2:04pm
Olanzapine, an antipsychotic medication that is often used off-label, has proved highly effective in controlling breakthrough chemotherapy-induced nausea and vomiting.
Dr. Gomella on Neoadjuvant Hormonal Therapy Plus Zytiga
May 16th 2012, 2:04pm
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on Neoadjuvant Hormonal Therapy Combined With Abiraterone Acetate
Dr. Chapman on BRAF/MEK Combination for Melanoma
May 16th 2012, 2:02pm
Dr. Paul Chapman, from Memorial Sloan-Kettering Cancer Center, on Combining BRAF and MEK Inhibitors for Advanced Melanoma
Dr. Markman on PCP Awareness of Long-Term Side Effects
May 16th 2012, 2:01pm
Dr. Maurie Markman, Cancer Treatment Centers of America, on Primary Care Physician Awareness of Long-Term Chemotherapy Side Effects
PCPs Highly Unaware of Long-Term Chemotherapy Side Effects
May 16th 2012, 2:01pm
Many primary care providers and some oncologists are unaware of the long-term effects of four chemotherapy drugs used to treat two of the most common forms of cancer.
Dr. Goy on Crizotinib for Pediatric Patients With ALCL
May 16th 2012, 2:00pm
Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL
Crizotinib Active in ALK-Positive Pediatric Cancers
May 16th 2012, 2:00pm
Targeting the ALK gene with the oral agent crizotinib slowed or eliminated signs of tumor growth in pediatric patients with aggressive forms of neuroblastoma, ALCL, and IMTs.
Dr. Kazmi Discusses Olanzapine for Breakthrough CINV
May 16th 2012, 12:02pm
Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting
Nurses Discuss the Value of the ONS Annual Congress
May 10th 2012, 1:40pm
Oncology Nursing Society Congress
Five nurses discuss the value of the Oncology Nursing Society (ONS) Annual Congress, which is the largest meeting held specifically for oncology nurses.
Video Highlights From the 2012 ONS Congress
May 8th 2012, 10:38am
Oncology Nursing Society Congress
The Oncology Nursing Society (ONS) 37th Annual Congress video highlights, from OncLive TV.
ONS 37th Annual Congress Slideshow
May 7th 2012, 1:29pm
Oncology Nursing Society Congress
The Oncology Nursing Society (ONS) 37th Annual Congress Picture Slideshow.
Coverage Recap: ONS 37th Annual Congress
May 7th 2012, 12:40pm
Oncology Nursing Society Congress
A recap of our coverage from the Oncology Nursing Society 37th Annual Congress, in New Orleans, where thousands of oncology nurses gathered and shared valuable clinical insights.
Mary Gullatte Discusses Nursing Shortages
May 7th 2012, 12:25pm
Oncology Nursing Society Congress
Mary Gullatte, the president of the Oncology Nursing Society, Discusses Nursing Shortages
Carol Bush on the MCA Telehealth Network
May 7th 2012, 12:24pm
Oncology Nursing Society Congress
Carol Bush, BS, RN, from the The University of Kansas Cancer Center, on the Midwest Cancer Alliance Telehealth Network
All Patients With Colorectal Cancer Should Be Genetically Screened
May 7th 2012, 12:13pm
Oncology Nursing Society Congress
Universal tumor testing and a detailed personal and family history assessment are recommended for all patients with newly diagnosed colorectal cancer.
Erin McMenamin on HPV-related Head & Neck Cancer
May 6th 2012, 4:00pm
Oncology Nursing Society Congress
Erin McMenamin, MSN, from the Hospital of the University of Pennsylvania, on HPV-related Head & Neck Cancer Prognosis
ASCO/ONS Chemotherapy Safety Standards Updated to Include All Delivery Settings
May 6th 2012, 7:00am
Oncology Nursing Society Congress
The chemotherapy safety standards developed by ASCO and ONS were recently updated to reflect the fact that chemotherapy is delivered in a variety of settings.
Krista Rubin on Managing Ipilimumab-related Dermatitis
May 6th 2012, 6:00am
Oncology Nursing Society Congress
Krista Rubin, MS, RN, FNP-BC, from Massachusetts General Hospital Cancer Center, on Managing Ipilimumab-related Dermatitis.
Identifying Appropriate Patients for HER2-Targeted Therapies
May 6th 2012, 5:00am
Oncology Nursing Society Congress
Standards for identifying appropriate populations for treatment with HER2-targeted therapies are evolving.
Michael Eckenfels on Bortezomib Delivery Route Changes
May 5th 2012, 2:40pm
Oncology Nursing Society Congress
Michael Eckenfels, RN, OCN, from MD Anderson Cancer Center, on Changes to the Bortezomib Delivery Route.